Mersana Therapeutics
MRSN
MRSN
82 hedge funds and large institutions have $234M invested in Mersana Therapeutics in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
82
Holders Change
+13
Holders Change %
+18.84%
% of All Funds
1.81%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
26
Increased
33
Reduced
13
Closed
10
Calls
–
Puts
$58K
Net Calls
-$58K
Net Calls Change
-$58K
Top Buyers
| 1 |
GTC
1
Ghost Tree Capital
New York
|
$11.7M |
| 2 |
BI
2
BVF Inc
San Francisco,
California
|
$13.8M |
| 3 |
ACP
3
Acuta Capital Partners
Redwood City,
California
|
$4.82M |
| 4 |
4
BlackRock
New York
|
$19.2M |
| 5 |
5
Axa
Paris,
France
|
$2.09M |
